Keyphrases
Ezetimibe
100%
Statin Therapy
100%
Simvastatin
100%
Acute Coronary Syndrome
100%
Low-density Lipoprotein Cholesterol Level
57%
Monotherapy
42%
Lipid-lowering Therapy
28%
Median Time
14%
Confidence Interval
14%
Non-statins
14%
Intestinal Cholesterol Absorption
14%
Event Rate
14%
Placebo
14%
Nonfatal Myocardial Infarction
14%
Nonfatal Stroke
14%
Cardiovascular Mortality
14%
Cardiovascular Outcomes
14%
Stable Angina
14%
Coronary Revascularization
14%
Absolute Risk Difference
14%
Low-density Lipoprotein Cholesterol (LDL-C)
14%
Adverse Effects
14%
Gallbladder
14%
Cardiovascular Events
14%
Double-blind Randomized Trial
14%
Hazard Ratio
14%
Rehospitalization
14%
Kaplan-Meier
14%
Time-weighted Average
14%
Cardiovascular Risk
14%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
100%
Statin (Protein)
100%
Simvastatin
100%
Ezetimibe
100%
Low Density Lipoprotein Cholesterol
71%
Monotherapy
42%
Adverse Event
14%
Unstable Angina Pectoris
14%
Placebo
14%
Malignant Neoplasm
14%
Cerebrovascular Accident
14%
Heart Infarction
14%